TVB-3166
CAS No. 1533438-83-3
TVB-3166 ( —— )
产品货号. M26854 CAS No. 1533438-83-3
TVB-3166 诱导细胞凋亡并抑制体内异种移植肿瘤生长。 TVB-3166 是一种可逆、选择性脂肪酸合酶抑制剂(生化 FASN 和细胞棕榈酸酯合成的 IC50 分别为 42 nM 和 81 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥466 | 有现货 |
|
| 5MG | ¥787 | 有现货 |
|
| 10MG | ¥1321 | 有现货 |
|
| 25MG | ¥2399 | 有现货 |
|
| 50MG | ¥3562 | 有现货 |
|
| 100MG | ¥4941 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥867 | 有现货 |
|
生物学信息
-
产品名称TVB-3166
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述TVB-3166 诱导细胞凋亡并抑制体内异种移植肿瘤生长。 TVB-3166 是一种可逆、选择性脂肪酸合酶抑制剂(生化 FASN 和细胞棕榈酸酯合成的 IC50 分别为 42 nM 和 81 nM)。
-
产品描述TVB-3166 induces apoptosis and inhibits in-vivo xenograft tumor growth. TVB-3166 is a reversible and selective fatty acid synthase inhibitor (IC50s: 42 nM and 81 nM for biochemical FASN and cellular palmitate synthesis, respectively).(In Vitro):TVB-3166 (0.2 μM; 48 hours) inhibits β-catenin pathway signal transduction and transcriptional activity. TVB-3166 (0.02 or 0.20 μM; 7 days) suppresses palmitate synthesis and tumor cell viability in a dose-dependent manner. TVB-3166 (0.001-10 μM; 24 hours) induces cell death in CALU-6 non-small-cell lung tumor cells (cellular IC50: 0.10 μM) . (In Vivo):TVB-3166 (Oral gavage; 30-100 mg/kg/day) has the concentration is approximately 3-fold higher in plasma than the tumor. TVB-3166 (Oral gavage; 30-100 mg/kg/day) inhibits xenograft tumor growth. The 100 and 30 mg/kg groups had plasma and tumor concentrations of 7 and 2.9 μM, respectively .
-
体外实验Cell Proliferation Assay Cell Line:CALU-6 tumor cells Concentration:0.001, 0.01, 0.1, 1, 10 μMIncubation Time:24 hoursResult:Caused cell death in CALU-6 non-small-cell lung tumor cells with a cellular IC50 value of 0.10 μM.Cell Viability Assay Cell Line:90 different tumor cell lines (such as CALU-6 NSCLC cell line, NCI-H1975 NSCLC cell line) Concentration:0.02 or 0.20 μM Incubation Time:7 days Result:Dose-dependent induction of cell death was observed in all tumor cell lines.Western Blot Analysis Cell Line:COLO-205 and A549 cells Concentration:0.2 μM Incubation Time:48 hours Result:Inhibited β-catenin pathway signal transduction and transcriptional activity.
-
体内实验Animal Model:Female BALB-c-nude miceDosage:30, 60, or 100 mg/kg Administration:Oral gavage; once daily Result:Inhibited xenograft tumor growth.Animal Model:Female BALB-c-nude miceDosage:30, 60, or 100 mg/kg (Pharmacokinetic Study)Administration:Oral gavage; once daily Result:The concentration was approximately 3-fold higher in plasma than tumor. The 100 and 30 mg/kg groups had plasma and tumor concentrations of 7 and 2.9 μM, respectively.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Bacterial
-
研究领域——
-
适应症——
化学信息
-
CAS Number1533438-83-3
-
分子量384.483
-
分子式C24H24N4O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 62.5 mg/mL (162.56 mM)
-
SMILESCc1n[nH]c(c1C)-c1cc(C(=O)N2CC(C2)c2ccc(cc2)C#N)c(C)cc1C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Kunimoto S, et al. Reversal of resistance by N-acetyltyramine or N-acetyl-2-phenylethylamine in doxorubicin-resistant leukemia P388 cells. J Antibiot (Tokyo). 1987;40(11):1651-1652.
产品手册
关联产品
-
HFY-4A
HFY-4A 是一种 HDAC 抑制剂。HFY-4A 抑制乳腺癌细胞增殖、迁移和侵袭,并诱导细胞凋亡 (apoptosis)。HFY-4A 诱导免疫原性细胞死亡 (ICD)。HFY-4A 抑制乳腺癌异种移植小鼠模型中的肿瘤生长。
-
Triglycidyl isocyanu...
Triglycidyl isocyanurate 是一种三氮烯三环氧化物,具有抗肿瘤和抗血管生成活性。它通过激活 p53 抑制人非小细胞肺癌细胞的生长。异氰脲酸三缩水甘油酯烷基化并交联 DNA,从而抑制 DNA 复制。它诱导细胞凋亡,可用于癌症研究。
-
Targapremir-210
Targapremir-210 (TGP-210) 是一种有效的、选择性的 miR-210 (miRNA-210, microRNA-210) 抑制剂。 Targapremir-210 以高亲和力抑制 pre-miR-210 的加工 (Kd~200 nM)。Targapremir-210 是一种点击化学试剂。它含有 Azide 基团,可以和含有 Alkyne 基团的分子发生铜催化的叠氮-炔环加成反应(CuAAc)。还可以和含有 DBCO 或 BCN 基团的分子发生菌株促进的炔-叠氮环加成反应 (SPAAC)。
021-51111890
购物车()
sales@molnova.cn

